premise: The combined business, although not in the area of dermatology and eyecare, which Valeant claims would have got  an annual cost savings of $2.7bn, and would have been among the largest in the speciality pharmaceuticals sector <hypo>.
hypothesis: <hypo> should be "with a huge market share in both dermatology and eyecare"